Weidong P. Li

280 Wai Huan Dong Road
Guangzhou, 510006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations.

Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations.

Journal: mBio
Published: September 09, 2024

Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting.

Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting.

Journal: EBioMedicine
Published: August 26, 2023

Ruminococcaceae_UCG-013 Promotes Obesity Resistance in Mice.

Ruminococcaceae_UCG-013 Promotes Obesity Resistance in Mice.

Journal: Biomedicines
Published: October 29, 2022

Maternal periconceptional environmental exposure and offspring with congenital heart disease: a case-control study in Guangzhou, China.

Maternal periconceptional environmental exposure and offspring with congenital heart disease: a case-control study in Guangzhou, China.

Journal: BMC pregnancy and childbirth
Published: September 01, 2022

Validation of different personalized risk models of chemotherapy-induced nausea and vomiting: results of a randomized, double-blind, phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin.

Validation of different personalized risk models of chemotherapy-induced nausea and vomiting: results of a randomized, double-blind, phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin.

Journal: Cancer communications (London, England)
Published: April 23, 2022

Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants.

Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants.

Journal: Emerging microbes & infections
Published: March 01, 2022

Interpregnancy interval and subsequent perinatal risk of congenital heart disease in Guangzhou, Southern China: a retrospective cohort study, 2014-2019.

Interpregnancy interval and subsequent perinatal risk of congenital heart disease in Guangzhou, Southern China: a retrospective cohort study, 2014-2019.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Published: December 01, 2021

Dietary Zinc, Copper, and Selenium Intake and High-Risk Human Papillomavirus Infection among American Women: Data from NHANES 2011-2016.

Dietary Zinc, Copper, and Selenium Intake and High-Risk Human Papillomavirus Infection among American Women: Data from NHANES 2011-2016.

Journal: Nutrition and cancer
Published: September 23, 2021

Depression-/Anxiety-Like Behavior Alterations in Adult Slit2 Transgenic Mice.

Depression-/Anxiety-Like Behavior Alterations in Adult Slit2 Transgenic Mice.

Journal: Frontiers in behavioral neuroscience
Published: October 28, 2020

Associations between first-trimester intrauterine hematoma and twin pregnancy outcomes: a retrospective cohort study.

Associations between first-trimester intrauterine hematoma and twin pregnancy outcomes: a retrospective cohort study.

Journal: BMC pregnancy and childbirth
Published: September 09, 2020

3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium.

3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium.

Journal: Acta biomaterialia
Published: May 04, 2020

Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer.

Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer.

Journal: Neoplasma
Published: January 30, 2020
Showing 1-12 of 27

Last Updated: 09/26/2026